Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,530,743
+$39,831 QoQ
Shares Held
10,057
-12.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#1,770
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WHALEROCK POINT PARTNERS, LLC holds $17,592,227 across 8 Drug Manufacturers - General names. ABBV ranks #3 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,416 | $7,724,751 | |
| 2 | LLY |
ELI LILLY & Co
|
2,589 | $3,105,324 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
10,057 | $2,530,743 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,615 | $2,263,527 | |
| 5 | PFE |
Pfizer Inc
|
35,762 | $861,148 | |
| 6 | AMGN |
Amgen Inc
|
1,306 | $472,928 | |
| 7 | NVS |
Novartis AG
|
2,050 | $321,276 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,424 | $312,530 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,530,743 | 10,057 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,490,912 | 11,453 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,616,895 | 11,453 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,764,356 | 11,939 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,216,117 | 11,939 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,449,079 | 11,689 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,037,152 | 11,464 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,263,910 | 11,464 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,932,001 | 11,264 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,014,754 | 11,064 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,691,342 | 10,914 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,626,840 | 10,914 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,405,772 | 10,434 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,675,934 | 10,516 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,658,280 | 10,261 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,372,297 | 10,225 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,363,124 | 8,900 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,401,116 | 8,643 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,170,262 | 8,643 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $889,172 | 8,243 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $794,224 | 7,051 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $757,648 | 7,001 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $653,722 | 6,101 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $40,203 | 459 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $458,893 | 4,674 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $356,112 | 4,674 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||